Edition:
India

Vical Inc (VICL.OQ)

VICL.OQ on NASDAQ Stock Exchange Capital Market

1.26USD
11:09pm IST
Change (% chg)

$-0.03 (-2.33%)
Prev Close
$1.29
Open
$1.28
Day's High
$1.29
Day's Low
$1.25
Volume
11,702
Avg. Vol
32,433
52-wk High
$3.69
52-wk Low
$1.03

Chart for

About

Vical Incorporated researches and develops biopharmaceutical products based on its deoxyribonucleic acid (DNA) delivery technologies for the prevention and treatment of life-threatening diseases. The Company has approximately four active, independent, or partnered development programs in the areas of infectious disease including... (more)

Overall

Beta: 1.99
Market Cap(Mil.): $30.56
Shares Outstanding(Mil.): 11.40
Dividend: --
Yield (%): --

Financials

BRIEF-Vical Reports Q1 Loss Per Share $0.29

* VICAL REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATIONAL RESULTS

03 May 2018

BRIEF-Vical Reports Q4 Loss Per Share Of $0.21

* VICAL REPORTS FOURTH QUARTER 2017 FINANCIAL AND OPERATIONAL RESULTS

15 Mar 2018

BRIEF-Vical Announces Restructuring To Focus Resources On Hsv-2 And Antifungal Clinical Programs

* VICAL ANNOUNCES RESTRUCTURING TO FOCUS RESOURCES ON HSV-2 AND ANTIFUNGAL CLINICAL PROGRAMS

31 Jan 2018

Competitors

  Price Chg
Sanofi SA (SASY.PA) €69.22 +0.21
Novartis AG (NOVN.S) CHF75.60 +0.10
GlaxoSmithKline plc (GSK.L) 1,501.00 -45.00
AstraZeneca plc (AZN.L) 5,201.00 -28.00
Merck & Co., Inc. (MRK.N) $60.93 -0.54
Pfizer Inc. (PFE.N) $36.33 -0.19
Roche Holding Ltd. (ROG.S) CHF216.45 --
Roche Holding Ltd. (RO.S) CHF221.20 -2.40
Genocea Biosciences Inc (GNCA.OQ) $0.91 -0.02
Agenus Inc (AGEN.OQ) $2.32 -0.12

Earnings vs. Estimates